Dave Rosa - CEO, NeuroOne - The Next Frontier of Neurology

Dave Rosa is President & Chief Executive Officer of NeuroOne ( https://nmtc1.com/ ), a developmental-stage medical technology company developing high-definition, minimally invasive thin film electrodes for the diagnosis and treatment of various neurological conditions ( https://nmtc1.com/technology ). The company’s initial focus is on epilepsy and the fast‑growing neurostimulation device market.

Mr. Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products.

In addition to CEO roles with early-stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets.

Mr. Rosa holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.

IMPORTANT EPISODE LINKS -

Electrochemical Testing of a New Polyimide Thin Film Electrode for Stimulation, Recording, and Monitoring of Brain Activity -

https://pmc.ncbi.nlm.nih.gov/articles/PMC9611492/

First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity—Part 1: Biocompatibility Testing -

https://pmc.ncbi.nlm.nih.gov/articles/PMC9100917/

#NeuroOne #DaveRosa #MinimallyInvasive #ThinFilmElectrodes #Theranostics #Stereoelectroencephalography #NeurologicalConditions #Epilepsy #MovementDisorders #ChronicPain #PsychiatricDisorders #Glioblastoma #CognitiveDisorders #Neurostimulation #NerveAblation #BloodBrainBarrier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research